PTD-DBM PTD-DBM is a peptide that has shown remarkable results in hair growth studies, potentially rivaling minoxidil in some preclinical models
Your pediatrician can help you interpret the theoretical risks (minimal absorption due to peptide size) against your personal health priorities
The system consists of MnO 2 nanosheets, which acts as a fluorescence quencher, GSH-activated MRI contrast agent, and a DNA nanocarrier
doi: 10.1161/CIRCULATIONAHA.125.074545 Summary Keywords cardiovascular outcomes, SGLT2 inhibitors, GLP-1 agonists, combination therapy, heart failure, renal outcomes Citation Aristizbal-Colorado D, Corredor-Rengifo D, Sierra-Castillo S, Lpez-Corredor C, Vernaza-Trujillo D-A, Weir-Restrepo D, Izquierdo-Condoy JS, Ortiz-Prado E, Rico-Fontalvo J, Gmez-Mesa J-E, Abreu-Lomba A and Rivera-Martnez W-A (2025) A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists a comprehensive review
While patients in the study achieved meaningful weight loss, individual results varied: The research group earlier documented two primary drivers that contributed to patients stopping their medication: cost or insurance coverage limitations and side effects, with the former being the dominant reason
3 Likes SNK July 9, 2024, 4:46pm #19 Thought this to be interesting
